Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 2—February 2020

Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand

Anna Vesty, Gary McAuliffe, Sally Roberts, Gillian Henderson, and Indira BasuComments to Author 
Author affiliations: Auckland City Hospital, Auckland, New Zealand (A. Vesty, G. McAuliffe, S. Roberts, G. Henderson, I. Basu); Labtests, Auckland (G. McAuliffe)

Main Article

Table 1

Prevalence of antimicrobial resistance in Mycoplasma genitalium strains from community and SHC patients, Auckland, New Zealand, 2017*

Genotypic-resistance profile Frequency, %
Community patients SHC patients All patients
23S rRNA parC gyrA
Wild type 20.8 24.2 22.2
Macrolide + 60.4 48.5 55.6
Macrolide + fluoroquinolone + + 12.5 12.1 12.3
Macrolide + fluoroquinolone + + + 2.1 15.1 7.4
Fluoroquinolone + 4.2 0 2.5

*SHC, sexual health clinic; +, positive; –, negative.

Main Article

Page created: January 20, 2020
Page updated: January 20, 2020
Page reviewed: January 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.